San Diego, CA, United States of America

Jinghua Hu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Santolecan Pharmaceuticals LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jinghua Hu. Retrieved from https://idiyas.com/inventor/jinghua-hu-6lf10iug

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jinghua Hu: Innovator in Drug Delivery Systems

Introduction

Jinghua Hu is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in drug delivery systems. Her innovative work has led to the development of unique compounds that enhance the efficacy of drug delivery.

Latest Patents

Jinghua Hu holds a patent for "Taxane-lipid-polysaccharide dual conjugates, preparation methods thereof and uses thereof." This invention pertains to a group of taxane-lipid-polysaccharide dual conjugates, a process for their preparation, and their applications in pharmaceutical compositions. The invention also includes a series of intermediates for the preparation of these dual conjugates, which serve as effective drug delivery vehicles.

Career Highlights

Jinghua Hu is currently associated with Santolecan Pharmaceuticals LLC, where she continues to advance her research and development efforts. Her work focuses on creating innovative solutions that address critical challenges in drug delivery.

Collaborations

Jinghua has collaborated with notable colleagues, including Xiaohai Li and Yikang Shi, to further enhance the impact of her research in the pharmaceutical industry.

Conclusion

Jinghua Hu's contributions to drug delivery systems exemplify her commitment to innovation in the pharmaceutical field. Her work not only advances scientific knowledge but also has the potential to improve patient outcomes through enhanced drug delivery methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…